retatrutide ly3437943 triple agonist glp-1 gip glucagon LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: From discovery to clinical proof of concept What Is Retatrutide? The Triple
Description
Glucagon-Like Peptide-1 Attenuates Endothelial Barrier Injury in Diabetes via cAMP/PKA Mediated Down-Regulation of MLC Phosphorylation
2,5-7 GLP-1 receptors are present throughout the body, including the skin, central nervous system (eg, hypothalamus, brainstem, amygdala, hippocampus, cerebellum, spinal cord), vagus nerve, gastrointestinal system, pancreas, kidneys, and lungs
By Gabriel Alizaidy, MD, MS, and Starling Krentz, MS What are GLP-1 medications
She recommends looking for snacks that are rich in protein and fiber but low in fat
Epicardial fat in heart failure patients with mid-range and preserved ejection fraction
Our guide on how to inject GLP-1 peptides covers the technique in full detail with illustrations
